Mirror, Mirror 2024 is your opportunity to explore the impact of policy choices on health and well-being across 10 countries, including the U.S. Read the report here.

Prescription Drugs

Overview Resources

Rows of pills

Controlling Health Care Costs

Key Provisions of Drug Pricing Proposals

publication / Apr 26, 2021

prescription drug prices in the US

Controlling Health Care Costs

Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?

Issue Briefs / Oct 05, 2017

Pharmacist and patient discussing prescription drugs

Controlling Health Care Costs

The Case for Drug-Pricing Reform — The Cost of Inaction

blog / May 26, 2021

Featured

Pills pouring out into a mans hand

Controlling Health Care Costs

Allowing Medicare to Negotiate Drug Prices

Explainer / May 05, 2021

Medicare recipient sorting prescriptions

Controlling Health Care Costs

Inflation Rebate Penalty for Drug Companies

Explainer / Jun 17, 2021

Woman and pharmacist speaking, both wearing masks

Controlling Health Care Costs

Medicare Part D Redesign

Explainer / May 05, 2021

Doris Hölzl, pharmacist, gives FFP2 masks to a customer in a pharmacy in Berlin-Wilmersdorf as part of the free distribution of FFP2 masks to risk groups.

Controlling Health Care Costs

External Reference Pricing: The Drug-Pricing Reform America Needs?

Issue Briefs / May 27, 2021

senior woman on phone looks at pill packets on table

Controlling Health Care Costs

How Federal Drug-Pricing Proposals Could Affect Medicaid

blog / Aug 19, 2021

blue pills in machine manufactured with white gloved hand in background

Controlling Health Care Costs

Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs

blog / Aug 18, 2021

Search content about
Prescription Drugs

Drug reference pricing

Controlling Health Care Costs

Pharmaceutical Reference Pricing: Does It Have a Future in the U.S.?

Issue Briefs / Sep 10, 2018

drug prices in other countries

Controlling Health Care Costs

Three Essentials for Negotiating Lower Drug Prices

Blog / Aug 22, 2018

Generic drugs, which may be less afrodable due to proposed CREATES amendment

Controlling Health Care Costs

Proposed CREATES Amendment Could Impede the Availability of Affordable Generic Drugs

Blog / Jul 17, 2018

Controlling Health Care Costs

Anticompetitive Efforts to Block Affordable Drugs: A Patient’s Story and Policy Solutions

Issue Briefs / Jun 13, 2018

Monopoly money representing high drug costs

Controlling Health Care Costs

It’s the Monopolies, Stupid!

Blog / May 24, 2018

Prescription drug prices are soaring

Controlling Health Care Costs

Trump Administration’s Prescription Drug “Blueprint” to Tackle High U.S. Prices Will Need More Action Steps

Blog / May 17, 2018

FDA lower Rx drug prices

Achieving Universal Coverage

What Commissioner Gottlieb’s FDA Is Doing to Lower Prescription Drug Prices and Steps Congress Can Take to Help

Issue Briefs / Apr 26, 2018

pharmacist separates drugs

Controlling Health Care Costs

Policy Prescriptions for High Drug Costs: Experts Weigh In

Blog / Apr 03, 2018

opioid crisis

Controlling Health Care Costs

The U.S. Has Two Opioid Epidemics: The Federal Response Should Consider Both

Blog / Mar 22, 2018

Controlling Health Care Costs

340B Drug Discount Program: Why More Transparency Will Help Low-Income Communities

Blog / Mar 15, 2018

health care spending in US

Controlling Health Care Costs

Health Care Spending in the United States and Other High-Income Countries

Journal Article / Mar 13, 2018

Line Extension in Medicaid Drug Pricing

Controlling Health Care Costs

Bipartisan Deal Includes Important Step to Control Medicaid Drug Prices, But More Efforts Are Needed

Blog / Feb 26, 2018

1 … 5 6 7 8 9 10 11 12 13 14